Kilickap, S. Et Al. 2018. Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey. JOURNAL OF THORACIC ONCOLOGY , no.10 .

Kilickap, S., Ozturk, A., Karadurmus, N., Korkmaz, T., Yumuk, P., ÇİÇİN, İ., ... PAYDAŞ, S.(2018). Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey. JOURNAL OF THORACIC ONCOLOGY , no.10.

Kilickap, S. Et Al. "Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey," JOURNAL OF THORACIC ONCOLOGY , no.10, 2018

Kilickap, S. Et Al. "Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey." JOURNAL OF THORACIC ONCOLOGY , no.10, 2018

Kilickap, S. Et Al. (2018) . "Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey." JOURNAL OF THORACIC ONCOLOGY , no.10.

@article{article, author={S. Kilickap Et Al. }, title={Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey}, journal={JOURNAL OF THORACIC ONCOLOGY}, year=2018}